FDA/NIH Collaboration On Regulatory Science Includes Interest In Cancer, Pain Drugs and Vaccines
This article was originally published in The Pink Sheet Daily
Executive Summary
Grant program is small and open-ended at the outset, but officials offer a long list of needs. A public meeting to gather input on research priorities is set for April.